Research and Development Institute of Ecology and the Sustainable Use of Natural Resources

Protector of Penguins to be Recognized as 2023 Indianapolis Prize Winner

Retrieved on: 
Sunday, October 1, 2023

INDIANAPOLIS, Sept. 30, 2023 /PRNewswire/ -- The Indianapolis Prize – the world's leading award for animal conservation – will celebrate the world's preeminent animal conservationists at the Indianapolis Prize Gala presented by Cummins Inc. on Sept. 30, 2023, at the JW Marriott in downtown Indianapolis.

Key Points: 
  • Dr. Pablo Borboroglu will be Honored in Downtown Indianapolis on Sept. 30
    INDIANAPOLIS, Sept. 30, 2023 /PRNewswire/ -- The Indianapolis Prize – the world's leading award for animal conservation – will celebrate the world's preeminent animal conservationists at the Indianapolis Prize Gala presented by Cummins Inc. on Sept. 30, 2023, at the JW Marriott in downtown Indianapolis.
  • "Every two years, the international conservation community turns its eyes toward Indianapolis for the awarding of the Indianapolis Prize," Dr.
  • Dr. Pablo Borboroglu (pronounced: Bor-BOR-oh-glue), the 2023 awardee and ninth winner of the Prize, will receive a $250,000 unrestricted grant.
  • "I am incredibly grateful and honored to be named the 2023 Indianapolis Prize Winner," Borboroglu said.

Protector of Penguins to be Recognized as 2023 Indianapolis Prize Winner

Retrieved on: 
Sunday, October 1, 2023

INDIANAPOLIS, Oct. 1, 2023 /PRNewswire/ -- The Indianapolis Prize – the world's leading award for animal conservation – will celebrate the world's preeminent animal conservationists at the Indianapolis Prize Gala presented by Cummins Inc. on Sept. 30, 2023, at the JW Marriott in downtown Indianapolis.

Key Points: 
  • Dr. Pablo Borboroglu will be Honored in Downtown Indianapolis on Sept. 30
    INDIANAPOLIS, Oct. 1, 2023 /PRNewswire/ -- The Indianapolis Prize – the world's leading award for animal conservation – will celebrate the world's preeminent animal conservationists at the Indianapolis Prize Gala presented by Cummins Inc. on Sept. 30, 2023, at the JW Marriott in downtown Indianapolis.
  • "Every two years, the international conservation community turns its eyes toward Indianapolis for the awarding of the Indianapolis Prize," Dr.
  • Dr. Pablo Borboroglu (pronounced: Bor-BOR-oh-glue), the 2023 awardee and ninth winner of the Prize, will receive a $250,000 unrestricted grant.
  • "I am incredibly grateful and honored to be named the 2023 Indianapolis Prize Winner," Borboroglu said.

Grading your degradability claims: The latest for green marketers

Retrieved on: 
Monday, November 7, 2022

ECM advertised that its additive would make plastics fully biodegrade in 9 months to 5 years.

Key Points: 
  • ECM advertised that its additive would make plastics fully biodegrade in 9 months to 5 years.
  • Furthermore, ECM claimed that material treated with its additive had been tested and proven as biodegradable using ASTM D5511, a standard familiar to plastics people.
  • In addition, ECM issued its own Certificates of Biodegradability and Certificates of Assurance to convince industry clients and ultimately consumers that its additive was effective.
  • The FTC also challenged the specific 9 months to 5 years timeframe ECM touted in its promotional materials.
  • Another allegation in the complaint: that ECM violated the law by providing other companies with the "means and instrumentalities" to make deceptive green claims about their own products.
  • The FTC also announced two settlements with companies charged with making deceptive biodegradability claims for products manufactured with ECMs additive.
  • Theres more from the FTC on the green front, including a settlement with Michigan-based AJM Packaging Corporation, which makes paper plates, cups, bowls, napkins, etc.
  • It did for the FTC, due to a 1994 settlement with the company for allegedly deceptive environmental claims for its Green Label paper plates.
  • * 6 tips to take from the FTCs latest green cases Next:*

Medication Management Reform Leader Katherine H. Capps to Lead Panel at Precision Medicine Leaders Summit

Retrieved on: 
Wednesday, October 6, 2021

FALLS CHURCH, Va., Oct. 6, 2021 /PRNewswire-PRWeb/ --Katherine H. Capps, Co-founder and Executive Director of the Get the Medications Right Institute, will join leaders from the Get the Medications Right Institute on a panel at The Journal of Precision Medicine's Precision Medicine Leaders Summit on Pharmacogenomics taking place virtually on Tuesday, October 19.

Key Points: 
  • FALLS CHURCH, Va., Oct. 6, 2021 /PRNewswire-PRWeb/ --Katherine H. Capps, Co-founder and Executive Director of the Get the Medications Right Institute, will join leaders from the Get the Medications Right Institute on a panel at The Journal of Precision Medicine's Precision Medicine Leaders Summit on Pharmacogenomics taking place virtually on Tuesday, October 19.
  • The panel, "Improving Patient Outcomes Through the Integration of Pharmacogenomic Testing into Comprehensive Medication Management Care Models," will discuss the value of precision medicine and pharmacogenomic testing services in CMM care models.
  • The role of pharmacogenomics in the clinical setting is shifting from a reactive testing approach toward a preemptive model.
  • The goal of this panel is to educate health care professionals on the value of precision medicine and pharmacogenomic testing services in CMM care models.

Tabula Rasa HealthCare to Host Call to Discuss AJMC Publications

Retrieved on: 
Monday, September 27, 2021

Knowlton, Ph.D.; TRHC Chief Sales Officer, Kevin Boesen, PharmD; and TRHC Chief Scientific Officer and CEO, Precision Pharmacotherapy, Research and Development Institute,Jacques Turgeon, BPharm, PhD.

Key Points: 
  • Knowlton, Ph.D.; TRHC Chief Sales Officer, Kevin Boesen, PharmD; and TRHC Chief Scientific Officer and CEO, Precision Pharmacotherapy, Research and Development Institute,Jacques Turgeon, BPharm, PhD.
  • The conference call and webcast will be held on Tuesday, September 28, 2021, at 11:00 a.m.
  • Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events the fourth leading cause of death in the US.
  • TRHC's proprietary technology solutions, including MedWise, improve patient outcomes, reduce hospitalizations, and lower healthcare costs.